GTCM
RXDX

Gyon Technologies Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,285
Closed -$361K 478
2022
Q4
$361K Buy
+3,285
New +$361K 0.14% 165
2022
Q3
Sell
-28,532
Closed -$805K 650
2022
Q2
$805K Buy
+28,532
New +$805K 0.23% 126